Publication | Open Access

Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid organ transplant recipients

VaccinationTransplantationVaccine DevelopmentHumoral ResponseImmunologyHeterologous MrnaT Cell ImmunityHumoral ImmunityVaccine DesignMedicineVaccine ResearchViral ImmunityCellular ImmunityCovid-19